FDA expands pediatric indication for entrectinib and approves new pellet formulation
FDA Drug Safety / Drugs feed · 1d ago
Genentech
Medicine & Biotech · covered by 7 outlets this week · tracked since 2026-10-27
Press: 7 specialist outlet-days
Background
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Wikipedia ↗
Written by the Alivewire editors from the coverage below, 19h ago. Not medical advice; how the ratings work.
Coverage
FDA approves polatuzumab vedotin-piiq for previously untreated diffuse large B-cell lymphoma, not otherwise specified, and high-grade B-cell lymphoma
FDA Drug Safety / Drugs feed · 1d ago
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer
FDA Drug Safety / Drugs feed · 5d ago
FDA approves atezolizumab and hyaluronidase-tqjs for subcutaneous injection
FDA Drug Safety / Drugs feed · 5d ago
FDA approves inavolisib with palbociclib and fulvestrant for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, advanced breast cancer
FDA Drug Safety / Drugs feed · 5d ago
FDA approves atezolizumab for adjuvant treatment of muscle invasive bladder cancer in patients with molecular residual disease
FDA Drug Safety / Drugs feed · 5d ago
FDA approves atezolizumab in combination with chemotherapy for Stage III mismatch repair deficient colon cancer
FDA Drug Safety / Drugs feed · 5d ago
FDA approves atezolizumab in combination with chemotherapy for Stage III mismatch repair deficient colon cancer
FDA Drug Safety / Drugs feed · 9d ago
Genentech pays $100m upfront for Alector’s AL050
Longevity.Technology · 33d ago
Genentech, Alector partner on $1.2b Parkinson’s drug deal
Longevity.Technology · 36d ago